SLC6A3 and Parkinson disease: Whereas DAT-SPECT is a well-studied and widely accepted imaging method to monitor the PD-prodromal nigrostriatal neurodegeneration, the PDRP in the FDG-PET method is still discussed as a prodromal progression marker and thus should be considered as a supportive parameter to the results obtained with DAT-SPECT.